Therapy Areas: Allergy
13 October 2021 - Clinical evaluation company The IMA Group (IMA) revealed on Tuesday the completion of the acquisition of Diagnostics Research Group (DXRG) in San Antonio, Texas for an undisclosed am...
12 October 2021 - - The US Food and Drug Administration has approved US-based biopharmaceutical company Ocular Therapeutix, Inc's (NASDAQ: OCUL) Supplemental New Drug Application to broaden the D...
5 October 2021 - - US-based clinical-stage company Vedanta Biosciences' Phase 2 clinical trial of VE303, an orally administered investigational live biotherapeutic product in development for the ...
5 October 2021 - - The first patient has been dosed with SAB-185 in the Phase 3 ACTIV-2 COVID-19 trial, US-based biopharmaceutical company SAB Biotherapeutics said.

SAB-185 is a fully hum...
5 October 2021 - Biopharmaceutical company SAB Biotherapeutics (SAB) said on Monday that it has dosed the first patient with SAB-185 in the Phase 3 ACTIV-2 COVID-19 trial led by the National Institute...
1 October 2021 - Malaysia's drug regulator has given conditional approval for Chinese biopharmaceutical company Sinovac Biotech's (Nasdaq:SVA) COVID-19 vaccine to be used in young people age...
Related Headlines